Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (10): 829-833    DOI: 10.19485/j.cnki.issn2096-5087.2023.10.001
  论著 本期目录 | 过刊浏览 | 高级检索 |
孕前体质指数与妊娠糖尿病的剂量-反应关系
李娜娜1, 张师静1, 陈巧敏1, 栗浩然2, 王雅莉2
1.郑州大学附属郑州中心医院营养科,河南 郑州 450007;
2.郑州大学附属郑州中心医院,河南 郑州 450007
Dose-response relationship between pre-pregnancy body mass index and gestational diabetes mellitus
LI Nana1, ZHANG Shijing1, CHEN Qiaomin1, LI Haoran2, WANG Yali2
1. Department of Nutrition, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, China;
2. Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, China
全文: PDF(1088 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析孕前体质指数(BMI)与妊娠糖尿病(GDM)的剂量-反应关系,为制定合理的孕前BMI控制目标,优化GDM防控策略提供依据。方法 选择2021年郑州市中心医院入院登记的孕产妇为研究对象,收集人口学资料、家族史、孕产史和孕期血糖监测资料。建立限制性立方样条回归模型分析孕前BMI与GDM的剂量-反应关系,采用受试者操作特征曲线(ROC曲线)评价孕前BMI预测GDM发病的能力。结果 纳入2 279名孕产妇。年龄MQR)为29.0(5.0)岁。孕前BMI MQR)为21.1(3.8)kg/m2;其中,体重过轻312人,占13.69%;低正常体重825人,占36.20%;高正常体重730人,占32.03%;超重345例,占15.14%;肥胖67例,占2.94%。GDM患病392例,患病率为17.20%。限制性立方样条回归模型分析结果显示,孕前BMI、年龄与GDM呈线性剂量-反应关系,孕前BMI>21.1 kg/m2时,GDM发病风险随孕前BMI的增加而升高;年龄>29.0岁时GDM发病风险随年龄的增加而升高;>29.0岁组孕前BMI所致GDM发病风险的剂量-反应关系强度普遍高于≤29.0岁组(均P<0.05)。孕前BMI预测GDM发病风险的ROC曲线下面积为0.654(95%CI:0.624~0.684);孕前BMI以24.0 kg/m2为界值时,约登指数、灵敏度和特异度分别为0.238、0.472和0.766;孕前BMI以23.0 kg/m2为界值时,约登指数、灵敏度和特异度分别为0.195、0.342和0.853;孕前BMI以21.1 kg/m2为预警值时,约登指数、灵敏度和特异度分别为0.213、0.676和0.537。结论 孕前BMI与GDM呈线性剂量-反应关系,孕前BMI>21.1 kg/m2可增加GDM发病风险。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
李娜娜
张师静
陈巧敏
栗浩然
王雅莉
关键词 妊娠糖尿病孕前体质指数年龄剂量-反应关系    
AbstractObjective To explore the dose-response relationship between pre-pregnancy body mass index (BMI) and gestational diabetes mellitus (GDM), so as to provide insights into the cut-off values of pre-pregnancy BMI and optimizing GDM prevention and control strategies. Methods Pregnant women that admitted to Zhengzhou Central hospital in 2021 were recruited, and demographics, family history, pregnancy and delivery history and blood glucose levels during pregnancy were collected. The dose-response relationship between pre-pregnancy BMI and GDM was analyzed using restricted cubic spline (RCS) analysis. The predictive ability of pre-pregnancy BMI for GDM risk was evaluated using receiver operating characteristic (ROC) curve. Results A total of 2 279 participants were included in the study. The median age was 29.0 (interquartile range, 5.0) years. The median pre-pregnancy BMI was 21.1 (interquartile range, 3.8) kg/m2. There were 312 underweight women (13.69%), 825 women with low-normal weight (36.20%), 730 women with high-normal weight (32.03%), 345 overweight women (15.14%) and 67 obese women (2.94%).The prevalence of GDM was 17.20%. RCS analysis suggested a linear dose-response relationship between age, pre-pregnancy BMI and GDM (P<0.05). When pre-pregnancy BMI was higher than 21.1 kg/m2, the risk of GDM increased with pre-pregnancy BMI (P<0.05). When women aged over 29.0 years, the risk of GDM increased with age, and the dose-response relationship of GDM caused by pre-pregnancy BMI was stronger in the women aged over 29.0 years than in the women aged 29.0 years and below (P<0.05). The area under curve (AUC) was 0.654 (95%CI: 0.624-0.684). If the cut-off value of pre-pregnancy BMI was 23.0 kg/m2, the Youden index, sensitivity and specificity was 0.238, 0.472 and 0.766, respectively. If it was 24.0 kg/m2, the Youden index, sensitivity and specificity was 0.195, 0.342 and 0.853, respectively. If it was 21.1 kg/m2, the Youden index, sensitivity and specificity was 0.213, 0.676 and 0.537, respectively. Conclusion There is a linear dose-response relationship between pre-pregnancy BMI and GDM, and higher than 21.1 kg/m2 of the pre-pregnancy BMI could increase the risk of GDM.
Key wordsgestational diabetes mellitus    pre-pregnancy body mass index    age    dose-response relationship
收稿日期: 2023-04-25      修回日期: 2023-07-05      出版日期: 2023-10-10
中图分类号:  R714.25  
基金资助:河南省医学科技攻关计划联合共建项目(LHGJ20220863)
作者简介: 李娜娜,硕士,主管医师,主要从事营养工作
引用本文:   
李娜娜, 张师静, 陈巧敏, 栗浩然, 王雅莉. 孕前体质指数与妊娠糖尿病的剂量-反应关系[J]. 预防医学, 2023, 35(10): 829-833.
LI Nana, ZHANG Shijing, CHEN Qiaomin, LI Haoran, WANG Yali. Dose-response relationship between pre-pregnancy body mass index and gestational diabetes mellitus. Preventive Medicine, 2023, 35(10): 829-833.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.10.001      或      https://www.zjyfyxzz.com/CN/Y2023/V35/I10/829
[1] GUARIGUATA L,LINNENKAMP U,BEAGLEY J,et al.Global estimates of the prevalence of hyperglycaemia in pregnancy[J]. Diabetes Res Clin Pr,2014,103(2):176-185.
[2] 娜仁其木格,李冬梅,米林香,等.中国妊娠期糖尿病患病率的Meta分析[J].中国循证医学杂志,2018,18(3):280-285.
[3] STROBEL K M,KAFALI S G,SHIH S,et al.Pregnancies complicated by gestational diabetes and fetal growth restriction:an analysis of maternal and fetal body composition using magnetic resonance imaging[J]. J Perinatol,2023,43(1):44-51.
[4] JOHNS E C,DENISON F C,NORMAN J E,et al.Gestational diabetes mellitus: mechanisms,treatment,and complications[J]. Trends Endocrinol Metab,2018,29(11):743-754.
[5] LEE S M,SHIVAKUMAR M,PARK J W,et al.Long-term cardiovascular outcomes of gestational diabetes mellitus:a prospective UK Biobank study[J]. Cardiovasc Diabetol,2022,21(1):221-234.
[6] NAJAFI F,HASANI J,IZADI N,et al.Risk of gestational diabetes mellitus by pre-pregnancy body mass index:a systematic review and meta-analysis[J/OL]. Diabetes Metab Syndr,2021,15(4)[2023-07-05].https://doi.org/10.1016/j.dsx.2021.06.018.
[7] TORLONI M R,BETRÁN A P,HORTA B L,et al. Prepregnancy BMI and the risk of gestational diabetes:a systematic review of the literature with meta-analysis[J]. Obes Rev,2009,10(2):194-203.
[8] MORISSET A S,ST-YVES A,VEILLETTE J,et al.Prevention of gestational diabetes mellitus:a review of studies on weight management[J]. Diabetes Metab Res Rev,2010,26(1):17-25.
[9] 中华人民共和国卫生部.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006.
[10] BLACK M H,SACKS D A,XIANG A H,et al.The relative contribution of prepregnancy overweight and obesity,gestational weight gain,and IADPSG-defined gestational diabetes mellitus to fetal overgrowth[J]. Diabetes Care,2013,36(1):56-62.
[11] World Health Organization.Diet,nutrition and the prevention of chronic diseases report of the joint WHO/FAO expert consultation[EB/OL].[2023-07-05].http://www.who.int/dietphysicalactivity/publications/trs916/download/en.
[12] NAKANISHI K,SAIJO Y,YOSHIOKA E,et al.Severity of low pre-pregnancy body mass index and perinatal outcomes:the Japan Environment and Children's Study[J]. BMC Pregnancy Childb,2022,22(1):121-130.
[13] TEUFEL F,SEIGLIE J A,GELDSETZER P,et al.Body-mass index and diabetes risk in 57 low-income and middle-income countries:a cross-sectional study of nationally representative,individual-level data in 685 616 adults[J]. Lancet,2021,398(10296):238-248.
[14] CHENG P J,DUAN T.China's new two child policy:maternity care in the new multiparous era[J]. BJOG,2016,123(Suppl.3):7-9.
[15] 任艳军,刘庆敏,刘冰,等. 2009—2018年杭州市妊娠糖尿病发病趋势[J]. 预防医学,2020,32(3):244-247.
[16] LI Y Y,REN X H,HE L L,et al.Maternal age and the risk of gestational diabetes mellitus:a systematic review and meta-analysis of over 120 million participants[J/OL].Diabetes Res Clin Pr,2020,162[2023-07-05].https://doi.org/10.1016/j.diabres.2020.108044.
[17] 王丽君,甘培元,何丽雅,等.妊娠中期糖脂代谢水平与妊娠结局的相关性分析[J].预防医学,2018,30(8):762-765,770.
[18] MANDÒ C,ABATI S,ANELLI G M,et al.Epigenetic profiling in the saliva of obese pregnant women[J/OL].Nutrients,2022,14(10)[2023-07-05].https://doi.org/10.3390/nu14102122.
[19] SUN M T,LUO M J,WANG T T,et al.Effect of the interaction between advanced maternal age and pre-pregnancy BMI on pre-eclampsia and GDM in Central China[J/OL].BMJ Open Diabetes Res Care,2023,11(2)[2023-07-05].http://dx.doi.org/10.1136/bmjdrc-2023-003324.
[1] 杜昌翰, 高琳茜, 卢心雨, 赵渭娟, 李领. 1992—2021年我国老年人群口腔癌疾病负担的年龄-时期-队列分析[J]. 预防医学, 2025, 37(9): 870-874.
[2] 成灵灵, 阎亚琼, 白增华, 张晓刚, 郝丽婷, 杨慧莹. 先天性甲状腺功能减退症患儿年龄别体质指数Z评分变化轨迹及影响因素[J]. 预防医学, 2025, 37(8): 858-863.
[3] 姜欣跃, 刘洁楠, 高美伶, 王玉超, 洪伊娜 综述, 严剑波 审校. 电离辐射暴露与甲状腺癌的研究进展[J]. 预防医学, 2025, 37(5): 471-476,480.
[4] 史美琦, 殷玉华, 汪旭虹, 付元庆, 苗泽蕾, 胡文胜. 妊娠糖尿病孕妇植物性饮食模式与孕期体重增加的关联研究[J]. 预防医学, 2025, 37(5): 503-506.
[5] 蒋舒頔, 郭婷, 凌军军, 任婕, 张亮. 初次性行为年龄与妇科恶性肿瘤的孟德尔随机化研究[J]. 预防医学, 2025, 37(5): 516-520.
[6] 沈敏, 郁智慧, 朱爱韬. 1992—2021年中国慢性阻塞性肺疾病发病和死亡的年龄-时期-队列分析[J]. 预防医学, 2025, 37(2): 113-117.
[7] 郑灿杰, 尹志英, 何寒青, 周洋. 2005—2024年衢州市30岁以下人群乙型病毒性肝炎发病趋势及年龄-时期-队列分析[J]. 预防医学, 2025, 37(12): 1206-1210,1216.
[8] 马宵, 宁士龙. 1993—2021年中国归因于烟草的广泛耐药结核病疾病负担分析[J]. 预防医学, 2025, 37(12): 1266-1271.
[9] 白开智, 章光明, 吴晓虹, 王小红, 徐则林, 庞志峰. 中国内脏脂肪指数预测高血压风险研究[J]. 预防医学, 2025, 37(11): 1119-1123.
[10] 韩仁强, 缪伟刚, 俞浩, 陶然, 周金意. 2009—2021年江苏省肿瘤登记地区恶性肿瘤发病趋势及年龄变化分析[J]. 预防医学, 2025, 37(10): 979-984,990.
[11] 张荣艳, 顾思义, 杨梅, 沈建新, 崔俊鹏, 陆艳. 2012—2021年吴江区肺癌发病趋势及年龄变化分析[J]. 预防医学, 2025, 37(10): 1029-1034.
[12] 李傅冬, 何凡, 何寒清, 章涛, 古雪, 俞敏. 2004—2020年浙江省10岁以下儿童乙型病毒性肝炎发病的年龄-时期-队列分析[J]. 预防医学, 2024, 36(9): 737-740.
[13] 邢玉萍, 邢辉, 李淼, 高燕. 中老年人群抑郁症状与衰弱的关系研究[J]. 预防医学, 2024, 36(8): 649-653.
[14] 林凯, 刘雅文, 罗诗丽, 李衡, 李雪梅. 2008—2022年盐田区性传播疾病年龄、时期、队列分析[J]. 预防医学, 2024, 36(7): 584-589.
[15] 李文军, 李慧, 杨景元, 杨虹, 高雅, 杲柏呈, 李瑶, 张琦玥, 邱亚飞. 2008—2022年赤峰市丙型病毒性肝炎发病的年龄、时期、队列趋势分析[J]. 预防医学, 2024, 36(6): 514-517,522.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed